Isogenic cells cultured in the same nutrient-rich environment show heterogeneity in their 18 proliferation rate. To understand the differences between fast and slow-proliferating cells 19 and to identify markers for proliferation rate that can be used at the single-cell level, we 20 developed a method to sort cells by their proliferation rate, and performed RNA sequencing 21 (RNA-Seq) on slow, medium and fast proliferating subpopulations of pluripotent mouse 22 embryonic stem cells (mESCs) and immortalized mouse fibroblasts. We identified a core 23 proliferation-correlated transcriptome that is common to both cell types, to yeast, and to 24 cancer cells: fast proliferating cells have higher expression of genes involved in both protein 25 synthesis and protein degradation. In contrast to cells sorted by proliferation rate, RNA-seq 26 on cells sorted by mitochondria membrane potential revealed a highly cell-type specific 27 mitochondria-state related transcriptome. mESCs with hyperpolarized mitochondria are fast 28 proliferating, while the opposite is true for fibroblasts. In addition, cell-to-cell variation in 29 proliferation rate is highly predictive of pluripotency state in mESCs, with cells of more naïve 30 pluripotent character having a slower proliferation rate. Finally, we show that the 31 proliferation signature learned from sorted cells can predict proliferation from scRNAseq 32 data in both mESCs and in the developing nematode. While the majority of the 33 transcriptional-signature associated with cell-to-cell heterogeneity in proliferation rate is 34 conserved from yeast to embryos to differentiated cells to cancer, the metabolic and 35 energetic details of cell growth are highly cell-type specific. 36 37 38 cell-type, cultured in the same optimal environment [1]. Cell-to-cell heterogeneity in 41 proliferation rate has important consequences for population survival in bacterial antibiotic 42 resistance, stress resistance in budding yeast, and chemo-resistance in cancer [2][3][4][5][6][7][8][9][10]. 43
Introduction the mitochondria-based oxidative phosphorylation, which is the predominant form of 80 ATP-generation in differentiated cells [22] . It is unknown if this inter-population variation in 81 proliferation, transcriptome, and mitochondria extents to intra-population variation among 82 single cells within a single isogenic population. 83 84 Pluripotent stem cells exist in different pluripotency states called naïve or primed based 85 on culture conditions and embryonic origin [23] . Mouse ESCs reflect the naïve pluripotency 86 state of the blastocyst epiblast and can be cultured in either serum+LIF or 2i+LIF conditions, 87 the latter involving inhibitors of FGF/ERK and GSK3 pathways. Culture in 2i+LIF conditions 88 promotes a ground state more closely mirroring the in vivo situation with reduced 89 heterogeneity in pluripotency gene expression and different cell cycle profile when 90 compared to cells grown in serum+LIF [24] [25] [26] . Nevertheless, even in 2i+LIF conditions, 91 mESCs display a certain amount of cell-to-cell heterogeneity [27, 28] and it is unclear, how 92 this relates to heterogeneity in differentiated cell types when it comes to gene expression 93 and its link to proliferation rate. 94
95
To understand the relation between intra-population transcriptome heterogeneity and 96 heterogeneity in proliferation, we developed a FACS-based method to sort cells by 97 proliferation rate. We applied this method to mouse immortalized fibroblasts and to mESCs 98 and performed RNA-seq on fast, medium and slow proliferating cell sub-populations. We find 99 that ribosome-biogenesis (protein synthesis) and proteasome-related (protein degradation) 100 genes are highly expressed in fast proliferating fibroblasts and ESCs. Moreover, the 101 proliferation signature is conserved across cell-type and species, from yeast to cancer cells, 102 allowing us to predict the relative proliferation rate from the transcriptome; we use the gene 103 expression signature to correctly predict proliferation from scRNA-seq data not only in 104 mESCs, but also during C. elegans development, in spite of no nematode data going into the 105 initial model In contrast to the generality of this main transcriptional signature, many 106 mitochondria-related genes were upregulated in fast proliferating fibroblasts, yet 107 down-regulated in fast-proliferating mESCs. Consistent with this, the high mitochondria 108 membrane potential is indicative of slow proliferating fibroblasts, while in mESCs it is 109 characteristic of fast proliferating cells. Taken together, these results show the existence of a 110 core protein-synthesis and protein-degradation expression program that is conserved across 111 cell types and species, from yeast to mice, and a metabolic and energy-production program 112 that is highly cell-type specific. 113
114
Results 115 in proliferation rate in mammalian cells we developed a method for sorting single 118 mammalian cells by their proliferation rate (Figure 1) . The cell-permeable dye 119 carboxyfluorescein succinimidyl ester (CFSE) covalently binds to free amines within cells, 120 thus staining most intracellular proteins at lysine residues. We reasoned that in cell types 121 that divide symmetrically, such as embryonic stem cells and immortalized fibroblasts [29] , 122 the equal dilution of CFSE into the two daughter cells would enable us to count the number 123 of divisions that each cell had undergone. To eliminate confounding effects due to 124 differences in initial staining we used fluorescence-activated cell sorting (FACS) to obtain an 125 initially homogeneous cell population of cells with identical CFSE signals ( Figure 1A) measured CFSE signal should be relatively insensitive to cell-to-cell variation in protein 131 degradation. We cultured this sorted starting cell population for several generations, during 132 which time the CFSE signal decreases with each cell division ( Figure 1B) . Consistent with the 133 decrease in CFSE being mostly due to cell division, the population-level doubling time of 134 each cell type can be calculated based on the decrease in CFSE signal over time ( Figure 1C , 135 D), and these doubling times are consistent with those reported by other methods [32, 33] . 136 After five days for fibroblasts growing in MEF (mouse embryonic fibroblast) medium, and 137 three for ESCs grown in pluripotent ground-state promoting 2i+LIF conditions [34], we used 138 FACS to isolate cells with high, medium, and low CFSE signal, and performed RNA-seq on 139 each sub-population. This allowed us to identify genes whose expression is positively or 140 negatively correlated with proliferation rate within a single population ( Figure 1E ). 141 142 Slow-proliferating ESCs are of more naïve pluripotent character than fast-proliferating ESCs 143
Embryonic stem cells exhibit cell-to-cell heterogeneity in culture based on the 144 expression of naïve pluripotency marker genes such as Nanog, Stella (Dppa3) or Rex1 (Zfp42) 145 [35] [36] [37] . Although this heterogeneity is mostly apparent in ESCs cultured in serum+LIF, even 146 when cultured in ground state-pluripotency-promoting 2i+LIF conditions, the sub-population 147 of ESCs with low NANOG-levels displays propensity for lineage-priming and differentiation 148 [28, 38] . To determine if cell-to-cell variation in proliferation rate was caused by a 149 sub-population of mESCs initiating a differentiation program, we determined the fold-change 150 in expression between slow and fast proliferating sub-populations for a set of genes that are 151 upregulated during lineage commitment. We found no consistent enrichment of these 152 differentiation genes in fast versus slow proliferating cells, as they could be found to be 153 expressed in either population (Figure 2A ). However, the slow proliferating sub-population 154 did have higher expression of genes that are upregulated in naïve pluripotent cells, and in 2-cell stage embryos ( Figure 2B ,C), suggesting that slow proliferating mESCs are in a more 156 naïve pluripotent cell state than their fast proliferating counterparts. 157
159
Processes correlated with cell-to-cell heterogeneity in proliferation rate that are consistent 160 across cell-types and species 161 To identify functional groups of genes that are differentially expressed between fast and 162 slow proliferating cells within a single population we performed gene set enrichment analysis 163 (GSEA) [39, 40] ( Figure 3A and 3B) on mRNA-seq data from fast and slow proliferating 164 subpopulations. We found that, in both fibroblasts and ESCs, as well as in the budding yeast 165 S. cerevisiae, genes involved in ribosome-biogenesis and the proteasome are more highly 166 expressed in fast proliferating cells ( Figure 3C , 3D and Table S1 ). High expression of 167 ribosomal genes is a common signature for fast proliferating cells [12, 41] , and cancer cells Figure 3C ). mTORC1 (mammalian Target Of Rapamycin Complex 1) functions as a nutrient 176 sensor and regulator of protein synthesis, and is regulated by nutrient and cytokine 177 conditions that cause differences in proliferation [46, 47] . We find that, even in the absence 178 of genetic and environmental differences, mTORC1 is more active in fast proliferating cells. cells, and those genetic or environmental perturbations are not necessary to cause 191 differential expression of these pathways. 192 scRNA-seq of developing nematodes revleals that, compared to terminally differentiated cells, 194
proliferating cells have higher expression of ribosome biogenesis and proteasome genes 195
Single-cell RNA sequencing is a powerful method for understanding cell-to-cell 196 heterogeneity, but it suffers from high levels of technical noise at the single-gene level. In 197 addition, most commonly used markers (PCNA, Ki67) for measuring proliferation rates in bulk 198 populations are cell-cycle regulated genes; what is really being measured is the fraction of 199 the population that is proliferating, usually the fraction that is in S phase. Thus, these 200 markers cannot be used to predict proliferation rates from scRNAseq data. We reasoned that, 201 as the average expression of large sets of genes, many of which are highly expressed and 202 therefore have lower levels of technical noise, the ribosome biogenesis and proteasome 203 gene sets would be ideal for differentiating proliferating vs non-proliferating cells in ribosome-biogenesis may serve as cell-type independent reporters of growth rate. To test 217 this hypothesis we analyzed RNA-seq data from 528 cancer cell lines in the Cancer Cell Line 218 Encyclopedia [61] for which the doubling time is roughly known. As GSEA is a measure of 219 differential expression, we created a single common control sample as the median 220 expression of each gene across all 528 cancer cell lines, and used GSEA to calculate the NES 221 (Normalized Enrichment Score) for all gene sets between the single control and each cancer 222 cell line ( Figure 4A ). 223 224 Ribosome and proteasome-related gene sets were among the gene sets most highly 225 correlated with growth rate across all cancers ( Figure 4B ). The absolute values of the 226 correlation of all gene sets with the reported doubling time were low, possibly because the 227 doubling times of the cancer cell lines were not measured using exactly the same 228 experimental conditions as were used for the RNA-seq experiments. We also calculated the 229 correlation between measured doubling time and meta-PCNA [17, 62], an RNA-seq-based 230 method for estimating growth rate at the population level that is independent of ribosomal 231 or proteasomal gene expression, but found similar levels of correlation ( Figure 4C ). each other than with proliferation rate ( Figure 4D ), suggesting a strong mechanistic coupling 234 between increased protein production and a need for increased protein degradation. 235
236
Most functional groups enriched in both fast fibroblast and ESCs are positively 237 correlated with each other across the 528 cancer cell lines ( Figure 4D and Table S1 ). This is 238 not the case for gene sets whose expression is negatively correlated with intra-population 239 variation in proliferation rate. Several p53 related gene sets are strongly negatively correlated 240 with proliferation within both fibroblasts and ESCs ( Figure 4D and Table S1 ), but the results 241 are much more heterogeneous across cancer cell lines, possibly reflecting the cancer-specific 242 mutation status of genes in this pathway. 243
244
To test if the coupling between ribosome biogenesis and proteasome expression holds 245 across species, we analyzed the bulk RNA-seq data across developmental stages, covering 246 multiple organs in seven species [16] . A high correlation between ribosome biogenesis genes 247 expression and proteasome genes expression was found across all seven species ( Figure 4E ). 248
The coordinated expression change with developmental stages between ribosome 249 biogenesis genes and proteasome genes across different organs in seven species suggests 250 that the coordination between protein synthesis and degradation is common across all 251 species and cell-types ( Figure S1 ). 252
253
The major cell-type specific proliferation-correlated expression is in mitochondria and 254 metabolism related genes. 255
256
While the pattern of within-population proliferation-correlated expression in yeast, 257 fibroblasts and ESCs was broadly similar with regard to genes involved in protein synthesis 258 and degradation, the behavior of metabolic and mitochondria-related genes in fast and slow 259 proliferating subpopulations was highly cell-type specific. Mitochondria membrane and 260 respiratory chain-related gene sets were more highly expressed in fast proliferating 261 fibroblasts, but not in fast proliferating ESCs (Table 1) . These results are consistent with 262 differential mitochondrial states in ESCs when compared to differentiated cells like 263 fibroblasts [22] , which suggest the existence of different types of metabolism and 264 proliferation-related heterogeneity between pluripotent and differentiated cell-types. Fast 265 proliferating sub-populations of different cell-types display differential importance and 266 metabolic states related to mitochondria. We also observed cell-type specific differences in 267 glycolysis, fatty acid metabolism, and other metabolic processes, suggesting fundamental 268 differences in the metabolic pathways required for fast proliferation between pluripotent 269 (Table 1) . 270 Cell-to-cell heterogeneity in mitochondria state predicts variation in proliferation both in ESCs 273 and fibroblasts, but in opposite directions. 274 Mitochondrial membrane potential is a major predictor of cell-to-cell heterogeneity in 275 proliferation rate in budding yeast [9] . Mitochondria-related genes are more highly 276 expressed in the fast proliferating subpopulation of fibroblasts. In contrast, these genes are 277 slightly more highly expressed in the slow proliferating subpopulation of ESCs. This suggests 278 that the relation between cell-to-cell heterogeneity in mitochondria state and proliferation 279 may be different in these two cell types. To test the ability of mitochondrial membrane 280 potential to predict in proliferation rate in mammalian cells we used the mitochondria 281 membrane potential-specific dye TMRE to stain fibroblasts and ESCs, and performed both 282 RNA-seq and proliferation-rate assays on high and low TMRE sub-populations ( Figure 5A ). Table S2 ). This is consistent with the 289 opposite behavior of mitochondria-related gene sets in proliferation-rate sorted cells from 290 the two cell types. Figure 6B ). Thus, unlike the relationship between protein synthesis and degradation and 306 proliferation, the relation between mitochondria and proliferation is highly cell-type specific. 307
ESCs and differentiated cells like fibroblasts

308
To test this we sorted fibroblasts and ESCs by TMRE, and measured the doubling time.
In 311 addition, we tested the effect of ascorbic acid (vitamin C, an antioxidant) and O2 levels 312 (ambient 21% atmospheric vs. low 5% physiological levels). While there was no significant 313 effect of either ascorbic acid or O2 in either cell type (Table S3) , the transcriptome-data 314 correctly predicted the results of the experiment, with high TMRE fibroblasts proliferating 315 more slowly, while high TMRE ESCs proliferated more rapidly ( Figure 6C ). Thus, across yeast, 316
ESCs and fibroblasts, while mitochondria state and proliferation rate co-vary within a single 317 popopulation, the direction of this correlation is different between pluripotent ESCs and 318 other cell types. 319
320
Single mESCs proliferating at different rates due to media fall along the axis of mESCs sorted 321 by proliferation rate. 322
The above suggests that we should be able to use PCA space to predict proliferation 323 rates of single cells from scRNA-seq data. This is in contrast to current proliferation markers, 324 such as PCNA and Ki67 which are cell-cycle regulated, and whose expression will not 325 correlate with proliferation at the single-cell level. In addition, expression measurements for 326 single genes are noisy; we reasoned that the position of a single cell in PCA space should be 327 more robust, as it takes into account the expression of most genes in the cell. As a control we 328 projected expression data from mESCs grown in either serum+LIF or 2i+LIF conditions [63] 329 into the same PCA space from Figure 6 . The slower-proliferating 2i+LIF grown cells are 330 perfectly separated from faster-proliferating serum+LIF grown cells by PC1, and, indeed, fall 331 exactly along the fast-slow sorted mESC expression axis ( Figure 7A) , consistent with the 332 combination of PC1+PC2 representing cell-type specific cell-to-cell variation in 333 proliferation-correlated gene expression. We observed an inter-population relation between 334 PC1 (proliferation) and the expression of pluripotency markers, but no intra-population 335 relation ( Figure 7B ), which is inconsistent with our results of sorting by proliferation rate 336 ( Figure 2B ). This may be due to possiblity that technical noise in single cell sequencing 337 drowned out the heterogeneity in proliferation rate, incomparability across experiments and 338 labs, or that PCA is not sufficient to separate by both proliferation and pluripoency. Cells 339 grown in serum+LIF have higher cell-to-cell heterogeneity in gene sets associated with 340 proliferation rate compared with cells grown in 2i+LIF ( Figure 7C,D) , reflecting the higher 341 homogeneity associated with ground state pluripotency of 2i+LIF grown cells [24] . In summary, we have developed a method to sort cells by their proliferation rate and 345 have examined the whole picture of gene expression patterns related to cell-to-cell 346 heterogeneity in proliferation (Table S4 ). We found with that genes involved in protein proteasome and proteasome-related protein degradation) are highly expressed in fast 349 proliferating mammalian cells and yeast cells. Previous studies have reported that high 350 expression of the proteasome in fast-growing cells can degrade misfolded protein because 351 the fast protein synthesis in fast-growing cells will produce more incorrectly folded proteins 352 [47, 64, 65], which is consistent with our enrichment of proteasome-related gene sets in fast 353 proliferating cells. at several levels that slow proliferating cells were of more naïve ground state pluripotent 362 character than fast proliferating cells. First, this was supported by the fact that they displayed 363 higher expression of naïve pluripotency marker genes and markers of 2C-like cells ( Figure  364 2B,C). Second, we observed enrichment of E2F targets and genes involved in G1 S cell cycle 365 phase transition (Table 1) in our fast cycling ESC population, indicative of a shortened G1 366 phase as described normally for ESCs cultured in serum+LIF conditions [26] . This is also 367 consistant with the observation, that our ESC line proliferates much faster when cultured in 368 serum+LIF, when compared to the 2i+LIF conditions used in this study (S.F.G., unpublished). 369
Finally, although we could find differentiation genes to be expressed both in fast and slow 370 proliferating cells (Figure 2A) , we saw a number of differentiation pathways to be enriched 371 specifically in fast dividing ESCs (Table 1 ). In summary, even when ESCs are cultured in 372 ground-state pluripotency promoting 2i+LIF conditions, they display heterogeneity in 373 proliferation rate, with the slow proliferating being of more naïve pluripotent character when 374 compared to fast dividing cells. 375
376
While we observed ESCs to behave similar to other cell types like fibroblasts or yeast 377 when it comes to gene expression signatures characteristic of fast proliferating cells related 378 to protein synthesis and turnover ( Figure 3C ), we found a very different behavior when it 379 comes to regulation of metabolism. Although the growth rate can be predicted by 380 mitochondrial membrane potential in Saccharomyces cerevisiae [23], where it is negatively 381 correlated with proliferation rate like in fibroblasts as we show in this study, our results show 382 mitochondrial membrane potential to be positively correlated with proliferation rate in ESCs 383 (Figure 6) , which suggests mitochondrial membrane potential has different functions in 384 pluripotent cells when compared to differentiated cell types or yeast. This is corroborated by 385 our gene expression analysis of cells with high vs. low mitochondrial membrane potential fibroblasts with low mitochondrial membrane potential but on the contrary enriched in ESCs 388 with high mitochondrial membrane potential. Surprisingly, primed pluripotent stem cells 389 have been described to rely more non-oxidative, glycolysis-based metabolism than naïve 390 pluripotent stem cells [66-68], which appears in contradiction with our result that our slow 391 proliferating, mitochondria activity low ESCs being more naïve-like. However, TMRE is not a 392 direct measure of ATP generation by mitochondria; yeast cells that are repsiring and 393 producing all of their ATP using their mitochondria, and yeast cells unable to respire and 394 unable to produce any ATP using their mitochondria both have high TMRE signals [9] . 395 Differentiated cells in general rely more on oxidative metabolism than pluripotent cells, 396 therefore our fast proliferating ESCs could potentially reflect a more differentiated state. In 397 conclusion, we were able to show that pluripotent ESCs behave similarly to other cell types 398 in their relation between proliferation rate and aspects like protein turnover, but in the 399 opposite direction when it comes to their metabolic state. For our full understanding of the 400 pluripotent state it will be important to reveal why and how metabolism and proliferation 401 rate are regulated so differently when compared to differentiated cells. ESCs and fibroblasts were plated on 10 cm plates at 5.3x10 6 and 7.3x10 5 concentration, 422 respectively. Cells were expanded and counted for 7 days. To monitor distinct generations of 423 proliferating cells, carboxyfluorescein succinimidyl ester (CFSE, Thermo Fisher Scientific) was CFSE was dissolved in dimethyl sulfoxide at a concentration of 5 mM as stock solution and 426 CFSE was added to a 1 ml cell suspension, to a final concentration of 5uM or 10uM. After 427 addition of CFSE, cells were incubated at 37°C for 20 min. Then the cells were washed twice 428 with complete medium and maintained on ice until use in a buffer containing PBS, 2% serum 429 and 1% pen-strep. Cell viability was determined by DAPI (Biogen Cientifica) staining. Dye 430 signals were measured on an LSRII flow cytometer. 431
432
RNA-seq 433
To collect cells with different growth rates, cells were isolated by sorting at room 434 temperature according to the CFSE signal (median and high CFSE signal). ESCs and fibroblasts 435 were sorted into 1.5 ml Eppendorf tubes containing medium and were cultured for 3 days 436 and 5 days respectively in specific culture conditions as described earlier. For each cell line 437 three bins were sorted: the lowest 10%, the median 10% and the highest 10% CFSE. Cells 438 were sorted into prechilled 1.5-ml Eppendorf tubes containing 200 μl medium each. Cells 439 were then centrifuged at 1000 rpm for 5 min, the media removed and the resulting cell pellet 440 was used for RNA extraction. All bins were treated identically throughout the process. 
Cell sorting 454
For the CFSE sort (no TMRE), cells were stained with CFSE and DAPI, and we used FACS to 455 obtain a population of viable cells the same CFSE signal. We then grew cells for 3 or 5 days, 456 and every 24 hours measured the CFSE signal using flow cytometry. 457
For the TMRE sort for proliferation rate, cells were stained with CFSE and TO-PRO-3, and we 458 used FACS to obtain a population of G1 cells with the same CFSE signal. We then grow cells 459 for 3 or 5 days, and every 24 hours measured the CFSE signal using flow cytometry. 460
In order to have a homogeneous starting population, both cell types were stained with 461 Hoechst (10 ug/ml, Life Technologies) to pick cells in G0/G1 phase. Within this population, 462 cells were selected according to the proliferation rate on the peak of CFSE signal prior and high with a BD Influx cell sorter into prechilled 1.5 ml Eppendorf tubes containing 200 μl 465 medium each. Cells were then centrifuged at 1000 rpm for 5 min, the cell pellet was washed 466 with PBS and used for RNA extraction. All bins were treated identically throughout the 467 process. Cellular RNA was extracted using the Maxwell RNA Purification Kit and processed for 468 RNA sequencing. 469
Cell viability was determined by TO-PRO-3 (Thermo Fisher Scientific) staining. 470
471
To test the effect of O2 levels and ascorbic acid/vitamin C in both cell types, sorted cells from 472 each bin were plated into each of the four different conditions (low O2 (5%), normal oxygen 473 growing conditions, and with or without ascorbic acid/vitamin C (25 ug/ml, Sigma-Aldrich)) 474 in duplicate. After one day of recovery from the sorting, the cells were washed in PBS, were 475 trypsinized, and counted. After seeding the same initial number, the rest of the cells was 476 analyzed on a BD Fortessa analyzer. Every day a sample from each condition and replicate 477 was taken for counting, and stained with 50 nM TMRE, up to 3 days for ESCs and 5 days for 478 fibroblasts, and both TMRE and CFSE were measured by flow cytometry. 479
480
Gene set enrichment analysis (GSEA) 481 GSEA was performed using the GSEA software and the MSigDB (Molecular Signature 482 Database v6.2) [39, 40] . We use signal to noise (requires at least three replicates) or log2 483 ratio of classes (for experiments with less than three replicates) to calculate the rank of each 484 gene. The maximum number of genes in each gene set size was set to 500, the minimum to 485 15, and GSEA was run with 1000 permutations. [60]. For each cell we calculate average log2(TPM+1) for genes in "GO preribosome" gene set 490 and for genes in "GO proteasome complex" gene set, and a t-test was used to compare the 491 mean expression of all cells in each of the two groups. To see the corresponding pluripotent cell state of fast and slow proliferating mESCs, we 496 calculated mean expression of naïve pluripotent markers in four fast-proliferating and four 497 slow-proliferating replicates and log2(fast/slow) was calculated to compare genes expression 498 in fast proliferating subpopulation and slow proliferating sub-population. The same method 499 was applied to lineage commitment gene markers and 2C-like state gene markers. 500 501 CCLE [61]. To perform GSEA on there cancer cell data, we create a "control" sample in which 504 a gene's expression is the median expression all 528 samples. Then we apply GSEA to each of 505 these cancer cell lines with the "control" sample as control. 506 Spearman correlation between each gene set NES and growth rate across 528 cancer cell 507 lines was calculated to find the gene sets correlated with growth rate. Average expression 508 level (log2(TPM+1)) of 11 proliferation marker genes (PCNA, ZWINT, RFC3, LBR, TFDP1, 509 SNRPB, SMC4, NUSAP1, BIRC5, UBE2C, and TROAP) was calculated as meta-PCNA. To see the 510 behavior of gene sets that belongs to the functional groups in Figure 2C in cancer cell data, 511
we calculate spearman correlation of gene sets NES across 528 cancer cell lines. The GSEA results were first filtered to extract gene sets that at are significant (FDR<0.1) in at 515 least one of the samples. The NES values of the selected gene sets served as the input into 516 PCA without scaling or normalization. FactoMineR [73] was used to perform the PCA using a 517 covariance matrix. 518
519
Projection of scRNA-seq data into PCA space and calculation of weighted Euclidean 520 distance 521
To project scRNA-seq data into the PCA space, we first perform GSEA on the scRNA-seq data 522 from publication [63] . Identical to the method we used for the GSEA of 528 cancer cell lines, 523 we create a "control" sample, which is the average of the (median expression of serum+LIF 524 grown cells and the median expression of 2i+LIF grown cells). GSEA for each single cell from 525 both conditions, vs this single control, was used to get the NES for each gene set and for 526 each single cell. We then used this NES matrix multiplied by the covariance matrix of the PCA 527 to project the scRNA-seq data into the PCA space. 528
The weighted Euclidean distance was calculated by set the percent of variance that the 529 principal component can explain as the weight of the corresponding dimension of this 530 principal component in PCA space, Euclidean distance was calculated between each two 531 samples after every samples coordinates were multiplied with the corresponding weight. Gene sets in MSigDB were first filtered to remove gene sets with fewer than 15 genes or 535 more than 500 genes, leaving 13794 gene sets for analysis. The expression level of each gene 536 set was calculated as the mean of log2(TPM+1) for genes in the gene set and the CV for each 537 gene set was calculated seperatly for both serum+LIF and 2i+LIF grown cells. (average of log2(TPM+1)) of pluripotency markers (genes in Figure 2B ) vs predicted 642 proliferation rate (the PC1 described in Figure 6A Table 1 . Gene sets whose expression exhibits opposite correlations with growth between 651 fibroblasts and ESCs. Shown are representative gene sets whose expression is significantly 652 correlated with proliferation in either fibroblasts or ESCs, but whose expression changes with 653 proliferation in opposing directions. 
